NAUT
Price
$0.67
Change
-$0.01 (-1.47%)
Updated
Sep 2, 04:53 PM (EDT)
Capitalization
85.89M
63 days until earnings call
XBIT
Price
$3.02
Change
-$0.14 (-4.43%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
96.34M
65 days until earnings call
Interact to see
Advertisement

NAUT vs XBIT

Header iconNAUT vs XBIT Comparison
Open Charts NAUT vs XBITBanner chart's image
Nautilus Biotechnolgy
Price$0.67
Change-$0.01 (-1.47%)
Volume$124
Capitalization85.89M
XBiotech
Price$3.02
Change-$0.14 (-4.43%)
Volume$598
Capitalization96.34M
NAUT vs XBIT Comparison Chart in %
Loading...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NAUT vs. XBIT commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAUT is a Buy and XBIT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (NAUT: $0.68 vs. XBIT: $3.16)
Brand notoriety: NAUT and XBIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAUT: 49% vs. XBIT: 29%
Market capitalization -- NAUT: $85.89M vs. XBIT: $96.34M
NAUT [@Biotechnology] is valued at $85.89M. XBIT’s [@Biotechnology] market capitalization is $96.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAUT’s FA Score shows that 1 FA rating(s) are green whileXBIT’s FA Score has 1 green FA rating(s).

  • NAUT’s FA Score: 1 green, 4 red.
  • XBIT’s FA Score: 1 green, 4 red.
According to our system of comparison, XBIT is a better buy in the long-term than NAUT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAUT’s TA Score shows that 3 TA indicator(s) are bullish while XBIT’s TA Score has 6 bullish TA indicator(s).

  • NAUT’s TA Score: 3 bullish, 6 bearish.
  • XBIT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, XBIT is a better buy in the short-term than NAUT.

Price Growth

NAUT (@Biotechnology) experienced а -3.00% price change this week, while XBIT (@Biotechnology) price change was -1.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

NAUT is expected to report earnings on Nov 04, 2025.

XBIT is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XBIT($96.3M) has a higher market cap than NAUT($85.9M). XBIT YTD gains are higher at: -20.000 vs. NAUT (-59.524). XBIT has higher annual earnings (EBITDA): -25.88M vs. NAUT (-68.6M). XBIT (153M) and NAUT (148M) have equal amount of cash in the bank . XBIT has less debt than NAUT: XBIT (10.2M) vs NAUT (28.2M). NAUT (0) and XBIT (0) have equivalent revenues.
NAUTXBITNAUT / XBIT
Capitalization85.9M96.3M89%
EBITDA-68.6M-25.88M265%
Gain YTD-59.524-20.000298%
P/E RatioN/AN/A-
Revenue00-
Total Cash148M153M97%
Total Debt28.2M10.2M276%
FUNDAMENTALS RATINGS
NAUT vs XBIT: Fundamental Ratings
NAUT
XBIT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
9060
P/E GROWTH RATING
1..100
1006
SEASONALITY SCORE
1..100
n/a14

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NAUT's Valuation (10) in the null industry is somewhat better than the same rating for XBIT (71) in the Biotechnology industry. This means that NAUT’s stock grew somewhat faster than XBIT’s over the last 12 months.

NAUT's Profit vs Risk Rating (100) in the null industry is in the same range as XBIT (100) in the Biotechnology industry. This means that NAUT’s stock grew similarly to XBIT’s over the last 12 months.

XBIT's SMR Rating (95) in the Biotechnology industry is in the same range as NAUT (97) in the null industry. This means that XBIT’s stock grew similarly to NAUT’s over the last 12 months.

XBIT's Price Growth Rating (60) in the Biotechnology industry is in the same range as NAUT (90) in the null industry. This means that XBIT’s stock grew similarly to NAUT’s over the last 12 months.

XBIT's P/E Growth Rating (6) in the Biotechnology industry is significantly better than the same rating for NAUT (100) in the null industry. This means that XBIT’s stock grew significantly faster than NAUT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NAUTXBIT
RSI
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
74%
Bearish Trend 5 days ago
88%
Momentum
ODDS (%)
Bearish Trend 5 days ago
83%
Bullish Trend 5 days ago
67%
MACD
ODDS (%)
Bearish Trend 5 days ago
84%
Bullish Trend 5 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
84%
Bullish Trend 5 days ago
71%
Advances
ODDS (%)
Bullish Trend 9 days ago
80%
Bullish Trend 14 days ago
65%
Declines
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
84%
BollingerBands
ODDS (%)
N/A
Bearish Trend 5 days ago
85%
Aroon
ODDS (%)
Bearish Trend 5 days ago
81%
Bullish Trend 5 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRCHF0.140.01
+6.72%
Brainchip Holdings Ltd.
MCARY8.360.05
+0.60%
Mercari Inc.
BDRL0.04N/A
N/A
Blonder Tongue Laboratories, Inc.
BKPKF56.28N/A
N/A
Bank Polska Kasa Opieki
PCLB32.13N/A
N/A
Pinnacle Bancshares, Inc.

NAUT and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAUT has been loosely correlated with FHTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if NAUT jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAUT
1D Price
Change %
NAUT100%
-1.02%
FHTX - NAUT
44%
Loosely correlated
+1.00%
NRIX - NAUT
40%
Loosely correlated
-0.74%
IMNM - NAUT
40%
Loosely correlated
-3.94%
BDTX - NAUT
39%
Loosely correlated
-3.51%
RXRX - NAUT
38%
Loosely correlated
-3.39%
More

XBIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, XBIT has been loosely correlated with OBIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if XBIT jumps, then OBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XBIT
1D Price
Change %
XBIT100%
-6.78%
OBIO - XBIT
41%
Loosely correlated
+0.74%
GBIO - XBIT
38%
Loosely correlated
-2.76%
BEAM - XBIT
37%
Loosely correlated
-2.91%
IMNM - XBIT
36%
Loosely correlated
-3.94%
NAUT - XBIT
35%
Loosely correlated
-1.02%
More